Stock Analysis on Net

Humana Inc. (NYSE:HUM)

This company has been moved to the archive! The financial data has not been updated since October 30, 2024.

Selected Financial Data 
since 2005

Microsoft Excel

Income Statement

Humana Inc., selected items from income statement, long-term trends

US$ in millions

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

External Revenues
The data shows a consistent increasing trend in external revenues from 2005 to 2023, with a significant jump observed from 2013 onwards.
Income from Operations
Income from operations displayed fluctuating trends over the years, with a peak in 2019 followed by a decline in 2020 and a subsequent recovery until 2023.
Net Income Attributable to Humana
The net income attributable to Humana varied over the years, with significant fluctuations observed. There was a spike in 2017, followed by a drop in 2018, and a gradual increase until 2020 with fluctuations thereafter.

Balance Sheet: Assets

Humana Inc., selected items from assets, long-term trends

US$ in millions

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Current Assets
The trend in current assets shows a consistent increase over the years, reaching US$29,986 million by the end of 2023 from US$4,206 million in 2005. The growth appears steady with some fluctuations.
Total Assets
Total assets have also grown steadily, although with some fluctuations, from US$6,870 million in 2005 to US$47,065 million by the end of 2023. The growth rate accelerated notably after 2017.

Balance Sheet: Liabilities and Stockholders’ Equity

Humana Inc., selected items from liabilities and stockholders’ equity, long-term trends

US$ in millions

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Current Liabilities:
Current liabilities have shown a steady increase from 2005 to 2023, with a peak in 2021. This suggests a consistent need for short-term resources to meet obligations.
Total Liabilities:
Total liabilities have generally increased over the years, with fluctuations in growth rates. The liability amount has risen significantly from 2019 to 2022, indicating a potential higher financial risk.
Total Debt, Including Book Overdraft:
The total debt has experienced fluctuations but a general upward trend. A substantial increase can be observed from 2018 to 2021, followed by a moderate decline in the subsequent years, indicating varying financing strategies.
Stockholders’ Equity:
Stockholders' equity has grown consistently over the period, with a notable increase from 2009 to 2018. The dip in equity in recent years raises questions regarding the company's financial health and leverage.

Cash Flow Statement

Humana Inc., selected items from cash flow statement, long-term trends

US$ in millions

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Net Cash Provided by Operating Activities (in US$ millions)
The trend shows a generally increasing pattern over the years, with a significant rise from 2016 to 2017 and another notable increase from 2019 to 2020.
Net Cash (Used in) Provided by Investing Activities (in US$ millions)
This metric demonstrates a fluctuating trend with negative values recorded in most periods, indicating a consistent outflow for investment activities. However, a positive shift occurs from 2019 to 2020, followed by a substantial negative trend in 2022 and 2023.
Net Cash Provided by (Used in) Financing Activities (in US$ millions)
There is variation in this metric over the years, showing both positive and negative values. A notable negative trend is observed from 2017 to 2019, followed by a significant positive spike in 2020 before descending sharply in 2021 and 2022.

Per Share Data

Humana Inc., selected data per share, long-term trends

US$

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1, 2, 3 Data adjusted for splits and stock dividends.

Basic Earnings Per Share:
The basic earnings per share show a general upward trend from 2005 to 2010, peaking at 8.58 in 2011. There was a significant drop in 2014 to 4.11 but a remarkable surge in 2017 to 12.24 and a continuous increase reaching 20.09 in 2023.
Diluted Earnings Per Share:
Similar to basic earnings per share, diluted earnings per share exhibit a rising pattern over time. The data mirrors the basic EPS trends with minor variations, achieving a peak of 8.46 in 2011 and climbing steadily to 20.00 in 2023.
Dividend Per Share:
Dividend per share data is sparse in the early years but showcases a consistent growth trajectory from 2011 onwards. There is a noticeable increase from 1.90 in 2017 to 3.44 in 2023, indicating a commitment to rewarding shareholders.